标题
Cancer vaccines: Targeting KRAS-driven cancers
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 19, Issue 2, Pages 163-173
出版商
Informa UK Limited
发表日期
2020-03-14
DOI
10.1080/14760584.2020.1733420
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations
- (2019) Susumu Iiizumi et al. Cancers
- Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
- (2019) J Mazières et al. ANNALS OF ONCOLOGY
- Cancer Vaccines
- (2019) Peter J. DeMaria et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
- (2018) Matthew R. Janes et al. CELL
- Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations
- (2018) Allen Cohn et al. JOURNAL OF IMMUNOTHERAPY
- A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
- (2018) Tingting Wang et al. Nature Communications
- Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses
- (2018) Jasmin Quandt et al. OncoImmunology
- KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer
- (2018) Diana Casique-Aguirre et al. BMC CANCER
- Targeting metabolic reprogramming in KRAS-driven cancers
- (2017) Kenji Kawada et al. International Journal of Clinical Oncology
- Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer
- (2017) Pasi A. Jänne et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- T-Cell Transfer Therapy Targeting Mutant KRAS
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Personalized cancer vaccines: Targeting the cancer mutanome
- (2017) Xiuli Zhang et al. VACCINE
- Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers
- (2017) Laetitia Seguin et al. Cancer Discovery
- Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
- (2017) Jing Pan et al. Oncotarget
- Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques
- (2017) Biliana Todorova et al. Scientific Reports
- Kras and Tumor Immunity: Friend or Foe?
- (2017) Jane Cullis et al. Cold Spring Harbor Perspectives in Medicine
- A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling
- (2016) Sai Krishna Athuluri-Divakar et al. CELL
- Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
- (2016) K. F. Bol et al. CLINICAL CANCER RESEARCH
- Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
- (2016) Zhong-Yi Dong et al. CLINICAL CANCER RESEARCH
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
- (2016) Brian I Rini et al. LANCET ONCOLOGY
- KRAS-related proteins in pancreatic cancer
- (2016) Karen M. Mann et al. PHARMACOLOGY & THERAPEUTICS
- Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
- (2016) P. Lito et al. SCIENCE
- Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
- (2016) S.H.T. Jorritsma et al. VACCINE
- Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
- (2016) Vincenzo Sforza et al. WORLD JOURNAL OF GASTROENTEROLOGY
- BGB-283 Deemed Effective in Phase I Study
- (2016) Cancer Discovery
- KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
- (2016) Barbara Bournet et al. Clinical and Translational Gastroenterology
- Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53−/− pancreatic ductal adenocarcinoma
- (2016) Vanaja Konduri et al. OncoImmunology
- Improving Prospects for Targeting RAS
- (2015) Harshabad Singh et al. JOURNAL OF CLINICAL ONCOLOGY
- RNA-Based Vaccines in Cancer Immunotherapy
- (2015) Megan A. McNamara et al. Journal of Immunology Research
- Live bacterial vaccine vectors: An overview
- (2015) Adilson José da Silva et al. BRAZILIAN JOURNAL OF MICROBIOLOGY
- Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation
- (2014) Jamie E. Chaft et al. Clinical Lung Cancer
- A Listeria Vaccine and Depletion of T-Regulatory Cells Activate Immunity Against Early Stage Pancreatic Intraepithelial Neoplasms and Prolong Survival of Mice
- (2014) Bridget P. Keenan et al. GASTROENTEROLOGY
- DNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model
- (2014) T-Y Weng et al. GENE THERAPY
- The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors
- (2014) Osama E Rahma et al. Journal of Translational Medicine
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
- (2014) Chong Sun et al. Cell Reports
- Clinical evaluation of therapeutic cancer vaccines
- (2013) Chizuru Ogi et al. Human Vaccines & Immunotherapeutics
- An Updated View of the Intracellular Mechanisms Regulating Cross-Presentation
- (2013) Priyanka Nair-Gupta et al. Frontiers in Immunology
- Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy
- (2012) L. van de Laar et al. BLOOD
- Mutated Ras-Transfected, EBV-Transformed Lymphoblastoid Cell Lines as a Model Tumor Vaccine for Boosting T-Cell Responses Against Pancreatic Cancer: A Pilot Trial
- (2012) Boris Kubuschok et al. HUMAN GENE THERAPY
- A Phase II Trial of Salirasib in Patients with Lung Adenocarcinomas with KRAS Mutations
- (2011) Gregory J. Riely et al. Journal of Thoracic Oncology
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Mutated K-ras in Pancreatic Adenocarcinoma Using an Adjuvant Vaccine
- (2010) Ghassan K. Abou-Alfa et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
- (2010) Synne Wedén et al. INTERNATIONAL JOURNAL OF CANCER
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
- (2008) Antoun Toubaji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started